Proinflammatory cytokine and human immunodeficiency virus RNA levels during early Mycobacterium avium complex bacteremia in advanced AIDS

Journal of Infectious Diseases

Volumn 177, Issue 6, 1998, Pages 1746-1749

  Haas, David W ^a   Lederman, Michael M ^b   Clough, Lisa A ^b   Wallis, Robert S ^b   Chernoff, David ^b   Crampton, Sheri L ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BACTEREMIA; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTION RISK; INFLAMMATION; MYCOBACTERIUM AVIUM; PRIORITY JOURNAL;

EID: 0031802440     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517437     Document Type: Article

References (15)

1. Wallis RS, Amir-Tahmasseb M, Ellner JJ. Induction of interleukin 1 and tumor necrosis factor by mycobacterial proteins: the monocyte Western blot. Proc Natl Acad Sci USA 1990;87:3348-52.
2. 2-microglobulin in HIV-1-associated tuberculosis. J Infect Dis 1993;167:43-8.
3. Poli G, Fauci AS. The effect of cytokines and pharmacologic agents on chronic HIV infection. AIDS Res Hum Retroviruses 1992;8:191-7.
4. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-6.
5. Pierce M, Crampton S, Henry D, et al. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. N Engl J Med 1996;335:384-91.
6. Kern D, Collins M, Fultz T, et al. An enhanced sensitivity branched-DNA assay for quantitation of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 1996;34:3196-202.
7. Todd J, Pachl C, White R, et al. Performance characteristics for the quantitation of plasma HIV-1 RNA using branched DNA signal amplification technology. J Acquir Immun Defic Syndr Hum Retrovirol 1995;10:S35-44.
8. Takashima T, Ueta C, Tsuyuguchi I, Kishimoto S. Production of tumor necrosis factor a by monocytes from patients with pulmonary tuberculosis. Infect Immun 1990;58:3286-92.
9. Lederman MM, Georges DL, Kusner DJ, Mudido P, Giam C, Toossi Z. Mycobacterium tuberculosis and its purified protein derivative activate expression of the human immunodeficiency virus. J AIDS 1994;7:727-33.
10. Haug CJ, Aukrust P, Lien E, Muller F, Espevik T, Froland SS. Disseminated Mycobacterium avium complex infection in AIDS: immunopathogenic significance of an activated tumor necrosis factor system and depressed serum levels of 1,25 dihydroxyvitamin D. J Infect Dis 1996;173:259-62.
11. Aukrust P, Liabakk NB, Muller F, Lien E, Espevik T, Froland SS. Serum levels of tumor necrosis factor-α (TNF-α) and soluble TNF receptors in human immunodeficiency virus type-1 infection-correlations to clinical, immunologic, and virologic parameters. J Infect Dis 1994;169:420-4.
12. Thea DM, Porat R, Nagimbi K, et al. Plasma cytokines, cytokine antagonists and disease progression in African women infected with HIV-1. Ann Intern Med 1996;124:757-62.
13. Wallis RS, Helfand MS, Whalen CC, et al. Immune activation, allergic drug toxicity and mortality in HIV-positive tuberculosis. Tubercle Lung Dis 1996;77:516-23.
14. Newman GW, Gan HX, McCarthy PL, Remold HG. Survival of human macrophages infected with Mycobacterium avium intracellulare correlates with increased production of tumor necrosis factor-α and IL-6. J Immunol 1991;147:3942-8.
15. Havlir DV, Haubrich R, Hwang J, et al. Sequential HIV RNA levels in patients with disseminated M. avium complex (MAC): a case control study [abstract 360]. In: Program and abstracts of the 4th Conference on Retroviruses and Opportunistic Infections (Washington, DC). Alexandria, VA: Infectious Diseases Society of America, 1997:130.